Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock - Investing.com UK

Source: Investing.com UK · 2026-10-03T02:02:00+00:00

Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock Investing.com UK

BestAIBroker analysis

Finance-aware sentiment: slightly negative (-0.20 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 28/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: UK, SYRE.